Compare VKTX & WU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VKTX | WU |
|---|---|---|
| Founded | 2012 | 1851 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.8B |
| IPO Year | 2014 | 2006 |
| Metric | VKTX | WU |
|---|---|---|
| Price | $38.04 | $7.53 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 8 |
| Target Price | ★ $95.86 | $9.00 |
| AVG Volume (30 Days) | 2.5M | ★ 7.6M |
| Earning Date | 04-29-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 10.47% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $4,050,700,000.00 |
| Revenue This Year | N/A | $8.50 |
| Revenue Next Year | N/A | $4.73 |
| P/E Ratio | ★ N/A | $36.30 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $22.96 | $6.91 |
| 52 Week High | $43.15 | $10.35 |
| Indicator | VKTX | WU |
|---|---|---|
| Relative Strength Index (RSI) | 73.64 | 44.83 |
| Support Level | $33.65 | N/A |
| Resistance Level | $39.78 | $7.75 |
| Average True Range (ATR) | 1.92 | 0.20 |
| MACD | 1.07 | 0.05 |
| Stochastic Oscillator | 87.55 | 72.19 |
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Western Union provides domestic and international money transfers through its global network of over 500,000 outside agents. The company handled almost 290 million transactions in 2025 and is the largest money transfer company in the world.